Patents by Inventor Laurence Boumsell

Laurence Boumsell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL MEANS FOR THE DIAGNOSIS AND THERAPY OF CTCL
    Publication number: 20080274468
    Abstract: The invention relates to a novel molecule, termed SC5 by the inventors, to a novel allelic form of p140, and to the biological applications of SC5 and p140 molecules, notably in the diagnosis and therapy of CTCL.
    Type: Application
    Filed: March 18, 2008
    Publication date: November 6, 2008
    Inventors: Armand Bensussan, Martine Bagot, Laurence Boumsell, Allessandro Moretta
  • Means for the diagnosis and therapy of CTCL
    Patent number: 7399595
    Abstract: A means for the diagnosis and therapy of T lymphomas, in particular Cutaneous T Cell Lymphomas (“CTCL”) are provided. Tumor markers which are universal for CTCL are described. More particularly, a molecule, termed SC5 by the inventors, an allelic form of p140, and biological applications of SC5 and p140 molecules, notably in the diagnosis and therapy of CTCL are described.
    Type: Grant
    Filed: December 18, 2001
    Date of Patent: July 15, 2008
    Assignee: Institut National de la Sante et de la Recherche Medicale (INSERM)
    Inventors: Armand Bensussan, Martine Bagot, Laurence Boumsell, Allessandro Moretta
  • Anti-CD71 monoclonal antibodies and uses thereof for treating malignant tumor cells
    Publication number: 20060286030
    Abstract: The present invention provides novel anti-CD71 monoclonal antibodies, in particular mouse-human chimeric anti-CD71 monoclonal antibodies, advantageously associated to effector cells for triggering ADCC mechanisms. Anti-CD71 antibodies, as well as pharmaceutical compositions containing them, are useful for inhibiting proliferation and/or killing malignant tumor cells, especially metastatic cutaneous and uveal melanoma cells.
    Type: Application
    Filed: June 15, 2005
    Publication date: December 21, 2006
    Inventors: Laurence Boumsell, Armand Bensussan, Jean Kadouche
  • Use of anti-cd100 antibodies
    Publication number: 20060233793
    Abstract: The invention relates to the use a BD16 and/or BB18 anti-CD100 antibody or of a chimeric or humanized or human form thereof, or a fragment thereof, for the therapy or diagnosis of a central nervous system disorder, more particularly a myelin disorder or a disease that affects oligodendrocytes, such as multiple sclerosis or HTLV-1 associated myelopathy or peripheral myelinating cells.
    Type: Application
    Filed: February 2, 2004
    Publication date: October 19, 2006
    Inventors: Marie-Francoise Belin, Pascale Giraudon, Laurence Boumsell, Armand Bensussan
  • Novel means for the diagnosis and therapy of ctcl
    Publication number: 20050074761
    Abstract: A means for the diagnosis and therapy of T lymphomas, in particular Cutaneous T Cell Lymphomas (“CTCL”) are provided. Tumor markers which are universal for CTCL are described. More particularly, a molecule, termed SC5 by the inventors, an allelic form of p140, and biological applications of SC5 and p140 molecules, notably in the diagnosis and therapy of CTCL are described.
    Type: Application
    Filed: December 18, 2001
    Publication date: April 7, 2005
    Inventors: Armand Bensussan, Martine Bagot, Laurence Boumsell, Allessandro Moretta